Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@xconomy.com 5 years ago

Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

@xconomy.com 5 years ago

Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones

@xconomy.com 5 years ago

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines